Tenaya Therapeutics, Inc. (TNYA)
0.6687
-0.03
(-4.10%)
USD |
NASDAQ |
Aug 24, 16:00
0.6687
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Total Liabilities (Quarterly) : 24.13M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.13M |
| March 31, 2026 | 28.88M |
| December 31, 2025 | 26.05M |
| September 30, 2025 | 22.11M |
| June 30, 2025 | 22.32M |
| March 31, 2025 | 24.56M |
| December 31, 2024 | 30.48M |
| September 30, 2024 | 27.98M |
| June 30, 2024 | 29.19M |
| March 31, 2024 | 26.72M |
| December 31, 2023 | 31.09M |
| September 30, 2023 | 28.51M |
| Date | Value |
|---|---|
| June 30, 2023 | 30.81M |
| March 31, 2023 | 29.93M |
| December 31, 2022 | 35.57M |
| September 30, 2022 | 29.98M |
| June 30, 2022 | 32.06M |
| March 31, 2022 | 32.40M |
| December 31, 2021 | 38.12M |
| September 30, 2021 | 28.10M |
| June 30, 2021 | 24.70M |
| March 31, 2021 | 12.96M |
| December 31, 2020 | 8.722M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 129.46M |
| Anavex Life Sciences Corp. | 7.059M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 93.54M |
| Shareholders Equity (Quarterly) | 69.41M |
| Debt to Equity Ratio | 0.0569 |
| Current Ratio | 4.522 |
| Net Debt Paydown Yield | 1.08% |